REGISTERED
on 20 Oct 2020
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
87492521 filed on 16th Jun 2017
Registration Number
6180502 registered on 20th Oct 2020
Correspondent Address
Andrea Christensen
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RAYLUMIS
Pharmaceutical preparations for the treatment of pain; none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs)
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of pain; none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs)
First Use Date in General
01st Jul 2020
First Use Date in Commerce
01st Jul 2020
Mark Details
Serial Number
No 87492521
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T 421118
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Apr 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 06th Apr 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 06th Apr 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Apr 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 06th Apr 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 20th Oct 2020 | REGISTERED-PRINCIPAL REGISTER |
| 17th Sep 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Sep 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Sep 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 15th Sep 2020 | SOU EXTENSION 4 GRANTED |